BOSTON – A Pittsfield pharmacist has been charged in federal court in Boston with allegedly diverting Adderall and Dextroamp-amphetamin (generic Adderall) from a national pharmacy chain. Joshua Bradley, 30, of Pittsfield, was charged with five counts of acquiring a controlled substance by fraud, deception and subterfuge. The defendant will make...

Washington, D.C. — The Justice Department, together with the Drug Enforcement Administration (DEA), today announced a $50 million settlement with Walmart Inc. (Walmart) to resolve allegations that Walmart pharmacies illegally filled thousands of invalid prescriptions for opioids and other controlled substances in violation of the Controlled Substances Act (CSA). “This...

CONCORD, N.H. – Massachusetts pharmacist Rima Gerges-Maalouf, 60, pleaded guilty in Federal Court to diverting controlled prescription drugs while working as a pharmacist in New Hampshire, U.S. Attorney Erin Creegan announces. As set forth in the plea agreement, in August 2024, Gerges-Maalouf served as a per diem pharmacist at a...

Washington, D.C - The founder and former Chief Executive Officer (CEO) Ruthia He of Done Global Inc., a California-based digital mental health company, was sentenced today to six years in prison and a fine of $1 million for orchestrating a scheme that used her company’s technology platform, compensation structure, and...

WASHINGTON D.C. - A federal jury in the Southern District of Texas convicted a Texas physician yesterday for unlawfully distributing more than a million pills of opioids and other dangerous controlled substances. “Medical physicians who exploit their prescribing authority for profit over patient care break an inherent trust with their...

WASHINGTON – This week the U.S. Drug Enforcement Administration released the established aggregate production quotas (APQ) for schedule I and II controlled substances and assessment of annual needs (AAN) for the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine for 2026. “DEA is committed to ensuring that patients can access the...

WASHINGTON – The U.S. Drug Enforcement Administration, in partnership with the Department of Health and Human Services (HHS), has issued a Fourth Temporary Extension of the COVID-19 Telemedicine Flexibilities for the Prescription of Controlled Medications , extending the current telemedicine flexibilities through December 31, 2026. Under these telemedicine flexibilities, DEA-registered...

WASHINGTON –The Drug Enforcement Administration, in collaboration with nearly 4,000 law enforcement partners across the country, will host the 29th National Prescription Drug Take Back Day this Saturday, October 25, from 10 a.m. to 2 p.m. At nearly 4,000 collection sites throughout the United States, DEA’s National Prescription Drug Take...

HARTFORD, Conn. - Marc H. Silverman, Acting United States Attorney for the District of Connecticut, Anish Shukla, Acting Special Agent in Charge of the New Haven Division of the Federal Bureau of Investigation, Stephen P. Belleau, Acting Special Agent in Charge of the Drug Enforcement Administration for New England, announced...

BOSTON – A Carver man has been sentenced in federal court in Boston for his involvement in an oxycodone conspiracy. Michael Atwood, 37, was sentenced by U.S. District Court Judge Denise J. Casper to 35 months in prison, to be followed by three years of supervised release. In November 2024...